drugset
drugset / Trial / NCT05065541

Positron Emission Tomography (PET) Imaging Study to Evaluate Enzyme Availability in the Central Nervous System Before and After CC-97489 Administration in Healthy Participants

NCT05065541 ↗

Phase 1 Completed 32 enrolled Celgene Corporation
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate enzyme availability in the central nervous system before and after CC-97489 administration in healthy participants

Timeline

Start
2021-09-24
Primary completion
2024-01-29
Completion
2024-01-29

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986368 Unknown — Oral

Indications

No indication recorded.